Qualitas Medical Group and Scicom to introduce an RTK-Antigen test platform for foreign workers

December 9, 2020


Qualitas Medical Group Sdn Bhd has teamed up with Scicom (MSC) Bhd as its technology partner to launch a series of affordable RTK-Antigen tests for foreign workers on the Covid-19-MY-Screening platform, which has been touted as Malaysia’s first integrated Covid-19 testing platform to help employers seamlessly manage all Covid-19 screening requirements.

Senior Minister for Security Ismail Sabri Yaakob announced on November 20th that foreign workers in all sectors are required to undergo an RTK-Antigen test.

In response to this, RTK-Antigen test screening has been subsidised under the Prihatin Screening Programme for eligible SOCSO contributors.

Employers can conveniently register their workers to be screened on-site by a member of the Qualitas medical team (at a location of their choice) or at a Qualitas clinic.

Scicom has described the Covid-19-MY-Screening platform as an end-to-end system that consists of a public e-commerce website and test centre management system.

“The system allows all Malaysian employers, along with both domestic and foreign employees to register for Covid-19 screenings, schedule test appointments and track test results prior to resuming their work duties” it said.

 “The combination of Qualitas’ network of general practice clinics and Scicom’s technological capabilities has resulted in the timely release of this platform to accelerate a safe return to work for our foreign workers and the public in general.” said Qualitas Medical Group Sdn Bhd Executive Chairman, Datuk Dr Noorul Ameen Mohamed Ishack.

Articles you might be interested in